DVAX übertreffen die 23 der letzten 40Schätzungen.
57%
Nächster Bericht
Datum des nächsten Berichts
18. Feb. 2026
Estimate forQ4 25(Revenue/ EPS)
$81.87M
/
$0.03
Implizierte Änderung vonQ3 25(Revenue/ EPS)
-13.71%
/
-85.71%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
+15.22%
/
-40.00%
Dynavax Technologies Corporation earnings per share and revenue
On 05. Nov. 2025, DVAX reported earnings of 0.21 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 64.71% surprise. Revenue reached 94.88 million, compared to an expected 95.88 million, with a -1.05% difference. The market reacted with a +6.70% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 81.87 million USD, implying an decrease of -85.71% EPS, and decrease of -13.71% in Revenue from the last quarter.
FAQ
What were Dynavax Technologies Corporation's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Dynavax Technologies Corporation reported EPS of $0.21, beating estimates by 64.71%, and revenue of $94.88M, -1.05% below expectations.
How did the market react to Dynavax Technologies Corporation's Q3 2025 earnings?
The stock price moved up 6.7%, changed from $10.30 before the earnings release to $10.99 the day after.
When is Dynavax Technologies Corporation expected to report next?
The next earning report is scheduled for 18. Feb. 2026.
What are the forecasts for Dynavax Technologies Corporation's next earnings report?
Based on 5
analysts, Dynavax Technologies Corporation is expected to report EPS of $0.03 and revenue of $81.87M for Q4 2025.